Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-19

Clinical Trial Update: Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT) [Phase 3]

View source ↗

Summary

Phase 3 trial update on field-directed photodynamic therapy for actinic keratosis reports completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Biofrontera Bioscience GmbH | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2016-12-19